An integrated multi-omics approach to identify regulatory mechanisms in cancer metastatic processes.
Cell Line, Tumor
Cell Movement
Colonic Neoplasms
/ genetics
Epigenomics
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Histones
Humans
Neoplasm Metastasis
/ genetics
Neoplasms
/ genetics
Prognosis
Proto-Oncogene Proteins c-jun
/ genetics
Transcription Factor AP-1
Transcription Factors
/ metabolism
Transcriptome
Colon cancer
Metastasis
Multi-omics
Probabilistic model
Transcriptional regulation
Journal
Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660
Informations de publication
Date de publication:
07 01 2021
07 01 2021
Historique:
received:
31
05
2020
accepted:
25
11
2020
entrez:
8
1
2021
pubmed:
9
1
2021
medline:
1
12
2021
Statut:
epublish
Résumé
Metastatic progress is the primary cause of death in most cancers, yet the regulatory dynamics driving the cellular changes necessary for metastasis remain poorly understood. Multi-omics approaches hold great promise for addressing this challenge; however, current analysis tools have limited capabilities to systematically integrate transcriptomic, epigenomic, and cistromic information to accurately define the regulatory networks critical for metastasis. To address this limitation, we use a purposefully generated cellular model of colon cancer invasiveness to generate multi-omics data, including expression, accessibility, and selected histone modification profiles, for increasing levels of invasiveness. We then adopt a rigorous probabilistic framework for joint inference from the resulting heterogeneous data, along with transcription factor binding profiles. Our approach uses probabilistic graphical models to leverage the functional information provided by specific epigenomic changes, models the influence of multiple transcription factors simultaneously, and automatically learns the activating or repressive roles of cis-regulatory events. Global analysis of these relationships reveals key transcription factors driving invasiveness, as well as their likely target genes. Disrupting the expression of one of the highly ranked transcription factors JunD, an AP-1 complex protein, confirms functional relevance to colon cancer cell migration and invasion. Transcriptomic profiling confirms key regulatory targets of JunD, and a gene signature derived from the model demonstrates strong prognostic potential in TCGA colorectal cancer data. Our work sheds new light into the complex molecular processes driving colon cancer metastasis and presents a statistically sound integrative approach to analyze multi-omics profiles of a dynamic biological process.
Sections du résumé
BACKGROUND
Metastatic progress is the primary cause of death in most cancers, yet the regulatory dynamics driving the cellular changes necessary for metastasis remain poorly understood. Multi-omics approaches hold great promise for addressing this challenge; however, current analysis tools have limited capabilities to systematically integrate transcriptomic, epigenomic, and cistromic information to accurately define the regulatory networks critical for metastasis.
RESULTS
To address this limitation, we use a purposefully generated cellular model of colon cancer invasiveness to generate multi-omics data, including expression, accessibility, and selected histone modification profiles, for increasing levels of invasiveness. We then adopt a rigorous probabilistic framework for joint inference from the resulting heterogeneous data, along with transcription factor binding profiles. Our approach uses probabilistic graphical models to leverage the functional information provided by specific epigenomic changes, models the influence of multiple transcription factors simultaneously, and automatically learns the activating or repressive roles of cis-regulatory events. Global analysis of these relationships reveals key transcription factors driving invasiveness, as well as their likely target genes. Disrupting the expression of one of the highly ranked transcription factors JunD, an AP-1 complex protein, confirms functional relevance to colon cancer cell migration and invasion. Transcriptomic profiling confirms key regulatory targets of JunD, and a gene signature derived from the model demonstrates strong prognostic potential in TCGA colorectal cancer data.
CONCLUSIONS
Our work sheds new light into the complex molecular processes driving colon cancer metastasis and presents a statistically sound integrative approach to analyze multi-omics profiles of a dynamic biological process.
Identifiants
pubmed: 33413550
doi: 10.1186/s13059-020-02213-x
pii: 10.1186/s13059-020-02213-x
pmc: PMC7789593
doi:
Substances chimiques
Histones
0
JunD protein, human
0
Proto-Oncogene Proteins c-jun
0
Transcription Factor AP-1
0
Transcription Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19Subventions
Organisme : NIGMS NIH HHS
ID : R35 GM131819
Pays : United States
Organisme : NIH HHS
ID : U54-GM114838
Pays : United States
Références
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16438-43
pubmed: 17940043
Oncogene. 2007 Jan 4;26(1):1-10
pubmed: 16799638
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
PLoS Biol. 2020 Jan 23;18(1):e3000583
pubmed: 31971940
J Biol Chem. 2014 Nov 7;289(45):31534-49
pubmed: 25274627
J Biol Chem. 2012 Sep 21;287(39):32467-78
pubmed: 22859303
Nat Commun. 2017 Feb 07;8:14400
pubmed: 28169291
Cell. 1988 Dec 2;55(5):875-85
pubmed: 3142689
Cancers (Basel). 2018 Feb 03;10(2):
pubmed: 29401653
J Cell Physiol. 2020 May;235(5):4407-4421
pubmed: 31613004
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4153-4158
pubmed: 28377514
J Drug Target. 2020 Jun;28(5):508-515
pubmed: 31865764
Oncotarget. 2016 Jan 5;7(1):860-72
pubmed: 26497212
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21931-6
pubmed: 21106759
Oncol Lett. 2015 Aug;10(2):810-814
pubmed: 26622575
Cancers (Basel). 2019 Dec 21;12(1):
pubmed: 31877793
Nature. 2016 Sep 22;537(7621):558-562
pubmed: 27626379
Mol Med Rep. 2015 Jul;12(1):503-9
pubmed: 25738465
Genome Biol. 2018 Aug 7;19(1):106
pubmed: 30086769
Nucleic Acids Res. 2017 Feb 28;45(4):e21
pubmed: 27794550
F1000Res. 2016 Apr 19;5:
pubmed: 27134739
Cancer Biol Ther. 2019;20(1):90-100
pubmed: 30148686
Oncol Rep. 2017 Nov;38(5):2587-2596
pubmed: 29048620
PLoS Comput Biol. 2013;9(9):e1003198
pubmed: 24039560
Cancer Res. 2017 Apr 15;77(8):1854-1867
pubmed: 28130225
Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302
pubmed: 29126174
Genome Res. 2018 Feb 2;:
pubmed: 29429977
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
Oncotarget. 2017 Jun 27;8(26):42238-42251
pubmed: 28178684
Carcinogenesis. 2014 Jun;35(6):1217-27
pubmed: 24403311
Mol Oncol. 2013 Oct;7(5):929-43
pubmed: 23800415
Cell Death Dis. 2014 May 29;5:e1263
pubmed: 24874735
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Br J Surg. 2006 Apr;93(4):465-74
pubmed: 16523446
Genome Res. 2018 Aug;28(8):1207-1216
pubmed: 29898900
BMC Med Genomics. 2011 Jan 20;4:9
pubmed: 21251323
PLoS One. 2010 Sep 28;5(9):
pubmed: 20927193
Nat Rev Cancer. 2003 Nov;3(11):859-68
pubmed: 14668816
Exp Mol Med. 2015 Jun 05;47:e166
pubmed: 26045254
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Genome Res. 2019 May;29(5):771-783
pubmed: 30962180
Nat Biotechnol. 2015 Mar;33(3):243-6
pubmed: 25748911
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773
pubmed: 30357393
BMC Genomics. 2017 Dec 21;18(1):985
pubmed: 29268714
Nucleic Acids Res. 2015 Apr 30;43(8):3998-4012
pubmed: 25791631
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Oncotarget. 2016 Feb 9;7(6):7012-28
pubmed: 26755651
PLoS Biol. 2008 Feb;6(2):e27
pubmed: 18271625
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Int J Cancer. 2000 May 15;86(4):480-8
pubmed: 10797259
Bioessays. 2014 Aug;36(8):798-806
pubmed: 24888900
Nat Methods. 2017 Oct;14(10):959-962
pubmed: 28846090
J Cell Mol Med. 2014 Oct;18(10):1975-91
pubmed: 24913443
Science. 2012 May 11;336(6082):736-9
pubmed: 22499810
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18020-5
pubmed: 21960440
Biochem Biophys Res Commun. 2013 Feb 22;431(4):658-63
pubmed: 23357422
Methods Mol Biol. 2014;1150:97-111
pubmed: 24743992
Nucleic Acids Res. 2012 Aug;40(15):e114
pubmed: 22718975
J Clin Oncol. 2013 May 10;31(14):1775-81
pubmed: 23530100
Gastroenterology. 2010 Mar;138(3):958-68
pubmed: 19914252
Nat Genet. 2018 Jan;50(1):73-82
pubmed: 29255264